Item 2. Management’s Discussion and Analysis
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
References in this report
(the “Quarterly Report”) to “we,” “us” or the “Company” refer to Pantages Capital Acquisition
Corporation (f/k/a “Aifeex Nexus Acquisition Corporation). References to our “management” or our “management team”
refer to our officers and directors, and references to the “Sponsor” refer to Aitefund Sponsor LLC. The following discussion
and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited financial
statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis
set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report
includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities
Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) that are not historical
facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All
statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this
“Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s
financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements.
Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,”
“project,” “should,” “would” and variations thereof and similar words and expressions are intended
to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect
management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance
or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information
identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements,
please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering (the “IPO”
described below) filed with the Securities Exchange Commission (the “SEC”) on December 5, 2024 (File No. 333-280986) (the
“Prospectus”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov.
Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or otherwise.
Overview
Pantages Capital Acquisition
Corporation (the “Company”, formerly known as “Aifeex Nexus Acquisition Corporation” and “Shepherd Ave Capital
Acquisition Corporation”) is a blank check company incorporated in the Cayman Islands on May 31, 2024 as an exempted company with
limited liability. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization,
reorganization or similar business combination involving the Company, with one or more businesses or entities (the “initial business
combination”). We intend to effectuate our initial business combination using cash from the proceeds of our IPO (as defined below),
Private Placement (as defined below), and the sale of our shares, debt or a combination of cash, equity and debt. We expect to continue
to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial business
combination will be successful.
Our Initial Public Offering
On December 6, 2024, the
Company consummated its initial public offering (the “IPO”) of 8,625,000 units (the “Public Units”), including
1,125,000 additional Units granted to the underwriters to cover over-allotments, if any (the “Over-Allotment Option”). Public
Unit consisting of one Class A ordinary share (the “Class A Ordinary Shares”) of the Company, par value $0.0001 per share
(the “Public Shares”), and one right (the “Rights”) of the Company, each right entitling the holder to receive
one-fifth of one Class A Ordinary Share for (the “Public Rights”). The Units were sold at an offering price of $10.00 per
Unit, generating total gross proceeds of $86,250,000.
Simultaneously with the closing
of the IPO, we consummated a private placement (the “Private Placement”) with Aitefund Sponsor LLC, our sponsor (the “sponsor”),
of an aggregate of 244,250 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating
gross proceeds to the Company of $2,442,500. Each Private Placement Unit consists of one Class A ordinary share (the “Private Placement
Shares”), and one Right (the “Private Placement Rights”). The terms and provisions of the Private Placement Shares and
Private Placement Rights in the Private Placement Units are identical to the Public Shares and Public Rights, respectively, except that,
subject to certain limited exceptions, the Private Placement Shares are subject to transfer restrictions until the consummation of the
Company’s initial business combination. On December 6, 2024, a total of $86,250,000 of the net proceeds from the IPO and the Private
Placement was deposited in a trust account (the “trust account”) established for the benefit of the Company’s Public
Shareholders at a U.S. based trust account, with Wilmington Trust, N.A., acting as trustee.
17
Since our IPO, our sole business
activity has been identifying, evaluating suitable acquisition transaction candidates and preparing for consummation of an initial business
combination. We presently have no revenue and have had losses since inception from incurring formation and operating costs. We have relied
upon the sale of our securities and loans from the sponsor and other parties to fund our operations.
The sales of the Private
Placement Units issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No commissions
were paid in connection with such sales.
Separation of Units
On January 23, 2025, the
Company announced that holders of the Company’s Public Units may elect to separately trade the Public Shares and Public Rights from
the Public Units, commencing on or about January 27, 2025.
The Class A ordinary shares
and rights were traded on the Nasdaq Global Market (“Nasdaq”) under the symbols “SPHA” and “SPHAR”,
respectively. Units not separated continued to trade on Nasdaq under the symbol “SPHAU.”
First Name Change
On March 11, 2025, the Company
held an extraordinary general meeting (the “First Shareholder Meeting”).
At the First Shareholder
Meeting, the shareholders of the Company, by special resolution, approved the proposal to amend Company’s amended and restated
memorandum and articles of associations (the “AR MAA”) to change the Company’s name from “Shepherd Ave Capital
Acquisition Corporation” to “Aifeex Nexus Acquisition Corporation” (the “First Name Change”).
Promptly following the approval,
the Company filed a Second Amended and Restated Memorandum and Articles of Association (the “2 nd AR MAA”) with
the Cayman Islands Companies Register to effect the First Name Change. In connection with the First Name Change, the Company’s ticker
symbols for its units, ordinary shares and rights changed from “SPHAU”, “SPHA”, “SPHAR”, in each case
to “AIFEU”, “AIFE”, and “AIFER”, and commenced trading under the new symbols on March 12, 2025.
Second Name Change
On August 5, 2025, the Company
held another extraordinary general meeting (the “Second Shareholder Meeting”).
At the Second Shareholder
Meeting, the shareholders of the Company, by special resolution, approved the proposal to amend Company’s 2 nd AR
MAA to change the Company’s name from “Aifeex Nexus Acquisition Corporation” to “Pantages Capital Acquisition
Corporation” (the “Second Name Change”).
Promptly following the approval,
the Company filed a Third Amended and Restated Memorandum and Articles of Association (the “Current MAA”) with the Cayman
Islands Companies Register to effect the Second Name Change. In connection with the Second Name Change, the Company’s ticker symbols
for its units, ordinary shares and rights changed from “AIFEU”, “AIFE”, and “AIFER”, in each case
to “PGACU”, “PGAC”, and “PGACR”, and commenced trading under the new symbols on August 8, 2025.
Results of Operations
We have neither engaged in
any operations nor generated any revenues to date. Our only activities from May 31, 2024 (inception) to June 30, 2025 were organizational
activities, those necessary to prepare for the IPO, described below, and, after the IPO, identifying a target company for an initial business
combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We may
generate non-operating income in the form of interest and dividend income on cash and investments held in the trust account. We incur
expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due
diligence expenses in connection with completing an initial business combination.
For the three months ended
June 30, 2025, we had a net income of $723,213, which consisted of interest and dividend income on cash and investments held in trust
account of $900,939 and partially offset by formation and operating costs of $177,726.
18
For the six months ended
June 30, 2025, we had a net income of $1,404,067, which consisted of interest and dividend income on cash and investments held in trust
account of $1,797,542 and partially offset by formation and operating costs of $393,475.
For the period from
May 31, 2024 (inception) through June 30, 2024, we had a net loss of $17,320, which consisted of formation and operating costs of $17,320.
Liquidity and Capital
Resources
The Company’s liquidity needs up to June
30, 2025 had been satisfied through a payment from the Sponsor of $25,000 for the Founder Shares to cover certain offering costs and the
proceeds from the public offering and private placements.
Following the closing of
the IPO and sale of the Private Placement Units on December 6, 2024, a total of $86,250,000 was placed in the trust account, and we had
$533,006 of cash held outside of the trust account, after payment of costs related to the IPO, and available for working capital purposes.
In connection with the IPO, we incurred $2,528,729 in transaction costs, consisting of $1,078,125 of underwriting fees, $862,500 of deferred
underwriting fees, and $588,104 of other offering costs.
As June 30, 2025, the Company
had cash of $294,644 and a working capital of $107,405.
For the six months ended
June 30, 2025, there was $413,362 of cash used in operating activities resulting from dividend earned on investments held in trust account
of $1,797,542, and the decrease in due to related parties of $31,188. The changes were offset by net income of $1,404,067, the decrease
in prepaid expenses of $2,139, and the increase in accounts payable and accrued expenses of $9,162.
For the period from May 31,
2024 (inception) through June 30, 2024, there was $0 of cash used in or provided by operating activities.
For the six months ended
June 30, 2025 and for the period from May 31, 2024 (inception) through June 30, 2024, there were no investing activities.
For the six months ended
June 30, 2025, there was $175,000 of cash provided by financing activity resulting from the proceeds from promissory note to related party.
For the period from May 31,
2024 (inception) through June 30, 2024, there were no financing activities.
We intend to use the funds
held outside the trust account to primarily identify and evaluate target businesses, perform business due diligence on prospective target
businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners,
review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete an initial business
combination.
In order to fund working
capital deficiencies or finance transaction costs in connection with an initial business combination, our directors, officers and the
sponsor (together, the “insiders”) or their affiliates or designees may, but are not obligated to, loan us funds as may be
required. If the Company completes the initial business combination, it would repay such loaned amounts. In the event that the initial
business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts
but no proceeds from the trust account would be used for such repayment. Up to $3,000,000 of such loans (the “Working Capital Loans”)
may be convertible into Units of the Company, at a price of $10.00 per Unit (the “Working Capital Units”) at the option of
the lender. As of June 30, 2025 and December 31, 2024, the Company had $175,000 and $0 borrowings under the Working Capital Loans.
We do not believe we will
need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the
costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than
the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination.
Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated
to redeem a significant number of our Public Shares upon completion of our initial business combination in which case we may issue additional
securities or incur debt in connection with such initial business combination.
19
Off-Balance Sheet Financing Arrangements
We have no obligations, assets
or liabilities, which would be considered off-balance sheet arrangements as of June 30, 2025. We do not participate in transactions that
create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would
have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial
assets.
Contractual Obligations
Registration Rights
The holders of the founder
shares and Private Placement Units, including any Working Capital Units of those issued upon conversion of Working Capital Loans will
be entitled to registration rights pursuant to a registration rights agreement signed on December 4, 2024 by and among the Company and
the insiders. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company
register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration
statements filed after the completion of our initial business combination and rights to require the Company to register for resale such
securities pursuant to Rule 415 under the Securities Act. The Company will bear the costs and expenses of filing any such registration
statements.
Underwriting Agreement
The underwriters received
a cash underwriting discount of $0.125 per Public Unit, or $1,078,125 in the aggregate and paid at the closing of the IPO and the exercising
of over-allotment option in part. In addition, the underwriters will be entitled to a deferred fee of $0.10 per Public Unit, or approximately
$862,500 in the aggregate upon the consummation of an initial business combination. The deferred fee will become payable to the underwriters
from the amounts held in the trust account solely in the event that the Company completes its initial business combination, subject to
the terms of the underwriting agreement dated December 4, 2024 by and among the Company, SPAC Advisory Partners LLC, and Kingswood Capital
Partners, LLC.
Critical Accounting Policies
Use of Estimates
The preparation of financial
statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results
could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible
that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements,
which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. We
did not identify any critical accounting estimates.
Recent Accounting Pronouncements
Management does not believe
that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our unaudited
financial statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting
company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
20
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.